The Coastal Bend Blood Center is thrilled to partner with Texas A&M University – Corpus Christi within the Collegiate Hero Program! In order to participate in the Collegiate Hero Program, find a blood drive on-campus and donate blood once a semester. If you are able to successfully donate blood at least once each semester, you will receive the medal of merit to wear during Commencement.
Did you know just one blood donation can save up to three lives? Donate the gift of life this week!
School is back in session & we need to erase the blood shortage we have experienced during the summer break. Like you must buy school supplies, we need you to stock up our blood supplies. Find a blood mobile near you & donate your lifesaving blood this week!
The Coastal Bend Blood Center is thrilled to launch the Collegiate Hero Program with Texas A&M Kingsville. In order to participate in the Collegiate Hero Program, find a blood drive on-campus and donate blood once a semester. If you are able to successfully donate blood at least once each semester, you will receive the medal of merit to wear during Commencement.
Every two seconds someone in the United States need blood. Please help us provide the needed blood to continue saving lives in the Coastal Bend! Someone needs your lifesaving donation today!
Sunday, July 16 St. Pius Catholic Church 9:00 am – 2:00 pm https://bit.ly/3WFFGG1 St. Andrew By the Sea 9:00 am – 1:00 pm https://bit.ly/3WE9PFM Church Unlimited 9:00 am -1:00 pm https://bit.ly/433avq1 St. Joseph Church 9:00 am – 1:00 pm https://bit.ly/42mE1Xq Fellowship of Oso Creek 9:30 am – 1:00 pm https://bit.ly/45AYR88 Monday, July 17 Aransas County Courthouse 10:00 am – 1:00 …
Hit a grand slam when you donate blood this week as donors will receive the NEW Baseball T-Shirt & a pair of Hooks Baseball Tickets, good for any home game. Make your lifesaving appointment today!
On behalf of the Coastal Bend Blood Center & Mattress Firm, we invite you to donate the gift of life during the 6th Annual Need For Life Blood Drive Series! Donors will be entered to win awesome prizes like a $1,000 Mattress Firm Shopping Spree, $500 H-E-B Gift Card, $100 Valero Gas Card, Blackstone Flat Grill & so much more!!
Receive the NEW Baseball T-Shirt, pair of Hooks Baseball Tickets & have a chance to win 4 Hooks Reserved Tickets or 4 Nature Bridge Caverns Tickets.
Summer is here & July is the perfect month to score tickets to watch our local Corpus Christi Hooks Baseball Team at Whataburger Field! The Blood Center is once again partnering with the Corpus Christi Hooks this July to give every blood donor a voucher for two general admission tickets for any home game at Whataburger Field for the 2023 baseball season.
Some medications may affect donor eligibility for the following reasons:
Anti-platelet agents affect platelet function, so people taking these drugs should not donate platelets for the
indicated time. You may still be able to donate whole blood or red blood cells by apheresis.
Anticoagulants or “blood thinners” are used to treat or prevent blood clots in the legs, lungs, or other parts of the
body, and to prevent strokes. These medications affect the blood’s ability to clot, which might cause excessive
bruising or bleeding when you donate. You may still be able to donate whole blood or red cells by apheresis.
Isotretinoin, finasteride, dutasteride acitretin and etretinate can cause birth defects. Your donated blood could
contain high enough levels to damage the unborn baby if transfused to a pregnant woman.
Thalomid (thalomide), Revlimid (lenalidomide), Erivedge (Vismodegib), Odomzo (sonidegib), Aubagio
(teriflunomide), Rinvoq (upadacitinib) may cause birth defects or the death of an unborn baby if transfused to a
pregnant woman.
Cellcept (mycophenolate mofetil) and Arava (leflunomide) are immunosuppressants which may cause birth
defects or the death of an unborn baby if transfused to a pregnant woman.
PrEP or pre-exposure prophylaxis involves taking a specific combination of oral medicines (i.e., short-acting
antiviral PrEP) or injections (i.e., long-acting antiviral PrEP) as a prevention method for people who are HIV negative
and at high risk of HIV infection. FDA has determined that the available data demonstrate that the use of PrEP or
PEP may delay the detection of HIV by currently licensed screening tests for blood donations, potentially resulting
in false negative results in infected individuals. Although “Undetectable = Untransmittable” for sexual transmission,
this does not apply to transfusion transmission.
PEP or post-exposure prophylaxis is a short-term treatment started as soon as possible after a high-risk exposure
to HIV to reduce the risk of infection. FDA has determined that the available data demonstrate that the use of PrEP
or PEP may delay the detection of HIV by currently licensed screening tests for blood donations, potentially resulting
in false negative results in infected individuals. Although “Undetectable = Untransmittable” for sexual transmission,
this does not apply to transfusion transmission.
ART or antiretroviral therapy is the use of a combination of HIV medicines (called an HIV regimen) to treat HIV
infection. HIV infection requires a permanent deferral despite treatment with ART. Antiretroviral drugs do not
fully eliminate the virus from the body, and donated blood from individuals infected with HIV taking ART can
potentially still transmit HIV to a transfusion recipient. Although “Undetectable = Untransmittable” for sexual
transmission, this does not apply to transfusion transmission.
Hepatitis B Immune Globulin (HBIG) is an injected material used to prevent hepatitis B infection following a
possible or known exposure to hepatitis B. HBIG does not prevent hepatitis B infection in every case, therefore,
persons who have received HBIG must wait to donate blood.
Experimental Medications are usually associated with a research study, and the effect on the safety of transfused
blood is unknown.
Algunos medicamentos afectan su elegibilidad como donante de sangre, por las siguientes razones:
Los agentes antiplaquetas afectan la función de las plaquetas, por lo que las personas que toman estos
medicamentos no deben donar plaquestas durante el tiempo indicado; Es posible que aún pueda donar sangre entera o
glóbulos rojos mediante aféresis.
Los anticoagulantes ó “diluyentes de la sangre” se usan para tratar o prevenir coágulos de sangre en las piernas, los
pulmones, u otras partes del cuerpo, y para prevenir accidents cerebrovasculares. Estos medicamentos afectan la
capacidad de coagulación de la sangre, lo que puede provocar hematomas ó sangrado excesivos cuando se dona. Es
posible que aún pueda donar sangre entera o glóbulos rojos mediante aféresis.
La isotretinoina, finasterida, dutasteride acitretina y etretinato pueden causar defectos de nacimiento. La
sangre donada podría contener niveles suficientemente altos como para dañar al feto si se transfunde a una
mujer embarazada.
Thalomid (talomida), Revlimid (lenalidomida), Erivedge (Vismodegib), Odomzo (sonidegib), Aubagio
(teriflunomida), y Rinvoq (upadacitinib) pueden causar defectos de Nacimiento o la Muerte del feto si se
transfunden a una mujer embarazada.
Cellcept (micofenolato mofetilo) y Arava (leflunomida) son immunosupresores que pueden causar defectos
de Nacimiento o la Muerte del feto si se transfunden a una mujer embarazada.
La PrEP o profilaxis previa a la exposición implica tomar una combinación específica de medicamentos orales
(es decir, PrEP antiviral de acción corta) o inyecciones (es decir, PrEP antiviral de acción prolongada) como
método de prevención para las personas que son VIH negativas y con alto riesgo de contraer el VIH infeccion.
La FDA ha determinado que los datos disponibles demuestran que el uso de PrEP o PEP puede retrasar la
detección del VIH mediante las pruebas de detección actualmente autorizadas para donaciones de sangre, lo
que podría generar resultados falsos negativos en personas infectadas. Aunque “Indetectable = Intransmisible”
para la transmisión sexual, esto no se aplica a la transmisión por transfusión.
La PEP o profilaxis post-tratamiento de accion corta que se incia lo antes posible después de una exposición
de alto riesgo al VIH para reducir el riesgo de infección. La FDA ha determinado que los datos disponibles
demuestran que el uso de PrEP o PEP puede retrasar la detección del VIH mediante las pruebas de detección
actualmente autorizadas para donaciones de sangre, lo que podría generar resultados falsos negativos en
personas infectadas. Aunque “Indetectable = Intransmisible” para la transmisión sexual, esto no se aplica a la
transmisión por transfusión.
ART o terapia antirretroviral es el uso de una combinación de medicamentos contra el VIH (llamado régimen
contra el VIH) para tratar la infección por VIH. La infección por VIH requiere un aplazamiento permanente a
pesar del tratamiento con TAR. Los medicamentos antirretrovirales no eliminant completamente el virus del
cuerpo, y la sangre donada de personas infectadas con el VIH que recibentratamiento antiretroviral aún puede
transmitir el VIH al receptor de una transfusión. Aunque “Indetectable = Intransmisible” para la transmisión
sexual, esto no se aplica a la transmisión por transfusión.
La Inmunoglobulina contra la Hepatitis B (IGHB) es un material inyectable que se utiliza para prevenir la
infección por hepatitis B después de una exposición posible ó conocida a la hepatitis B. La inmunoglobulina
contra la hepatitis B no previene la infección por hepatitis B en todos los casos, por lo tanto, las personas que
hayan recibido IGHB deben esperar para donar sangre.
Los Medicamentos experimentales suelen estar asociados con un estudio de investigación, y se desconoce
su efecto sobre la seguridad de la sangre transfundida.
